Longitudinal analysis of health care costs in patients with childhood onset inherited retinal dystrophies compared to healthy controls
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Longitudinal analysis of health care costs in patients with childhood onset inherited retinal dystrophies compared to healthy controls. / Kessel, Line; Kjellberg, Jakob; Ibsen, Rikke; Rasmussen, Annette; Nissen, Kamilla Rothe; la Cour, Morten.
In: BMC Ophthalmology, Vol. 22, No. 1, 466, 2022.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Longitudinal analysis of health care costs in patients with childhood onset inherited retinal dystrophies compared to healthy controls
AU - Kessel, Line
AU - Kjellberg, Jakob
AU - Ibsen, Rikke
AU - Rasmussen, Annette
AU - Nissen, Kamilla Rothe
AU - la Cour, Morten
N1 - Publisher Copyright: © 2022, The Author(s).
PY - 2022
Y1 - 2022
N2 - Background: We evaluated health care costs in patients with childhood onset visual impairment caused by inherited retinal dystrophies (IRD). Methods: The IRD cohort, identified from the Danish Registry of Blind and Partially Sighted Children, was compared to age- and sex-matched controls from the national, Danish population registry. Information on health care expenditures for somatic and psychiatric in- and outpatient services, purchase of prescription medications and paid assistance at home were obtained from national registries for the years 2002–2017. Results: We included 412 in the IRD cohort (6,290 person years) and 1656 (25,088 person years) in the control cohort. Average, annual health care expenditures from age 0–48 years of age were €1,488 (SD 4,711) in the IRD cohort and €1,030 (4,639) in the control cohort. The largest difference was for out-patient eye care (13.26 times greater, 95% confidence interval 12.90–13.64). Psychiatric in-patient expenditures were 1.71 times greater (95% CI 1.66–1.76) in the IRD cohort but psychiatric out-patient health care costs were comparable between groups. Conclusions: Health care costs were approximately 40% greater in the IRD cohort compared to an age- and sex-matched sample from the general Danish population. This is relevant in the current situation with a number of trials aimed at treating IRDs using genetically based therapies. Although eye care expenditures were many times greater, they made up < 10% of the total health care expenditures even in the IRD cohort. The reduced costs related to injuries in the visually impaired cohort was a surprising finding but may reflect a reduced propensity to seek medical care rather than a reduced risk of injuries.
AB - Background: We evaluated health care costs in patients with childhood onset visual impairment caused by inherited retinal dystrophies (IRD). Methods: The IRD cohort, identified from the Danish Registry of Blind and Partially Sighted Children, was compared to age- and sex-matched controls from the national, Danish population registry. Information on health care expenditures for somatic and psychiatric in- and outpatient services, purchase of prescription medications and paid assistance at home were obtained from national registries for the years 2002–2017. Results: We included 412 in the IRD cohort (6,290 person years) and 1656 (25,088 person years) in the control cohort. Average, annual health care expenditures from age 0–48 years of age were €1,488 (SD 4,711) in the IRD cohort and €1,030 (4,639) in the control cohort. The largest difference was for out-patient eye care (13.26 times greater, 95% confidence interval 12.90–13.64). Psychiatric in-patient expenditures were 1.71 times greater (95% CI 1.66–1.76) in the IRD cohort but psychiatric out-patient health care costs were comparable between groups. Conclusions: Health care costs were approximately 40% greater in the IRD cohort compared to an age- and sex-matched sample from the general Danish population. This is relevant in the current situation with a number of trials aimed at treating IRDs using genetically based therapies. Although eye care expenditures were many times greater, they made up < 10% of the total health care expenditures even in the IRD cohort. The reduced costs related to injuries in the visually impaired cohort was a surprising finding but may reflect a reduced propensity to seek medical care rather than a reduced risk of injuries.
KW - Childhood visual impairment
KW - Health care costs. Injury
KW - Inherited retinal dystrophy
U2 - 10.1186/s12886-022-02708-0
DO - 10.1186/s12886-022-02708-0
M3 - Journal article
C2 - 36460996
AN - SCOPUS:85143242580
VL - 22
JO - BMC Ophthalmology
JF - BMC Ophthalmology
SN - 1471-2415
IS - 1
M1 - 466
ER -
ID: 329304906